LRMR
#3356
Larimar Therapeutics, Inc. - Common Stock
2.5 3 USD
-0.05%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-5.24%
Monatliche Änderung
-34.11%
6 month change
-48.47%
Jahresänderung
-39.33%
Vorheriger Schlusskurs
2.6 7
Open
2.6 6
Tief
2.5 3
Hoch
2.6 9
Financials
2016
Current report, 15 Jul 2016
Larimar Therapeutics, Inc. current report, 15 July 2016
8-K
Quarterly report, Q2 FY2016
Larimar Therapeutics, Inc. quarterly report, Q2 FY2016
10-Q
Current report, 30 Jun 2016
Larimar Therapeutics, Inc. current report, 30 June 2016
8-K
Current report, 10 May 2016
Larimar Therapeutics, Inc. current report, 10 May 2016
8-K
Quarterly report, Q1 FY2016
Larimar Therapeutics, Inc. quarterly report, Q1 FY2016
10-Q
Current report, 09 Mar 2016
Larimar Therapeutics, Inc. current report, 09 March 2016
8-K
Current report, 03 Mar 2016
Larimar Therapeutics, Inc. current report, 03 March 2016
8-K
Current report, 18 Feb 2016
Larimar Therapeutics, Inc. current report, 18 February 2016
8-K
Current report, 20 Jan 2016
Larimar Therapeutics, Inc. current report, 20 January 2016
8-K
2015
Annual report, FY2015
Larimar Therapeutics, Inc. annual report, FY2015
10-K